CORRELATION BETWEEN CD200 EXPRESSION ON LEUKEMIC STEM CELLS AND RESPONSE TO TREATMENT IN DE-NOVO ADULT ACUTE MYELOID LEUKEMIA PATIENTS

Prognostic Impact of CD200 Expression in Pediatric Acute Lymphoblastic Leukaemia

ROLE OF CD200 IN ADULT PATIENTS WITH ACUTE MYELOID LEUKEMIA

Clinical Significance of CD200 and CD56 in Patients with Acute Lymphoblastic Leukemia

CD 11b and CD56 As Prognostic Markers in Acute Myeloid Leukemia

Correlating DNMT1, PCNA, and RB1 genes as new prognostic biomarkers

The Prognostic Value of Aberrant Expression of Cluster Differentiation Markers in Patients with Acute Leukemia

CD34 Expression in Adult Acute Myeloid Leukemia is an Independent Poor Prognostic Factor

RUNX3 gene expression confers an independent Overall survival advantage in non-M3 adult acute myeloid leukemia patients in Egypt.

Soluble CD44 is a promising biomarker with a prognostic value in breast cancer patients